Search research articles
Contact Us
Filters
Showing results (91-100 of 159) with videos related to
Page
of 16
Sort By:
Virchows Archiv : an International Journal of Pathology
|
February 9, 2022
Histologic analysis according to HER2 gene status in HER2 2 + invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations
Hye Won Hwang, Soon Auck Hong, Seok Jin Nam, et al.
Cancer Chemotherapy and Pharmacology
|
December 21, 2010
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
Eun Yoon Cho, Myung Hee Chang, Yoon La Choi, et al.
International Journal of Molecular Sciences
|
November 14, 2023
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Hae Hyun Jung, Ji-Yeon Kim, Eun Yoon Cho, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
June 24, 2009
Sonography of axillary masses: what should be considered other than the lymph nodes?
Eun Young Kim, Eun Young Ko, Boo-Kyung Han, et al.
Pathology
|
March 23, 2012
Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas
Eun Yoon Cho, Amitabh Srivastava, Kyeongmee Park, et al.
Radiology
|
December 16, 2014
Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancer
Seung Hyup Hyun, Hee Kyung Ahn, Yeon Hee Park, et al.
NPJ Breast Cancer
|
January 15, 2022
Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer
Ko Woon Park, Seon Woo Kim, Heewon Han, et al.
Journal of Clinical Medicine
|
September 26, 2020
Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer
Dohun Kim, Yujin Kim, Bo Bin Lee, et al.
The American Journal of Surgical Pathology
|
April 2, 2025
HER2 mRNA Score From Quantitative ERBB2 mRNA Expression of Oncotype Dx : Can It Replace the HER2 Immunohistochemistry?
Hyunwoo Lee, Jai Min Ryu, Se Kyung Lee, et al.
Scientific Reports
|
August 31, 2021
Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients
Soo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 159) with videos related to
Sort By:
Page
of 16
Virchows Archiv : an International Journal of Pathology
|
February 9, 2022
Histologic analysis according to HER2 gene status in HER2 2 + invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations
Hye Won Hwang, Soon Auck Hong, Seok Jin Nam, et al.
Cancer Chemotherapy and Pharmacology
|
December 21, 2010
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
Eun Yoon Cho, Myung Hee Chang, Yoon La Choi, et al.
International Journal of Molecular Sciences
|
November 14, 2023
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Hae Hyun Jung, Ji-Yeon Kim, Eun Yoon Cho, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|
June 24, 2009
Sonography of axillary masses: what should be considered other than the lymph nodes?
Eun Young Kim, Eun Young Ko, Boo-Kyung Han, et al.
Pathology
|
March 23, 2012
Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas
Eun Yoon Cho, Amitabh Srivastava, Kyeongmee Park, et al.
Radiology
|
December 16, 2014
Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancer
Seung Hyup Hyun, Hee Kyung Ahn, Yeon Hee Park, et al.
NPJ Breast Cancer
|
January 15, 2022
Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer
Ko Woon Park, Seon Woo Kim, Heewon Han, et al.
Journal of Clinical Medicine
|
September 26, 2020
Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer
Dohun Kim, Yujin Kim, Bo Bin Lee, et al.
The American Journal of Surgical Pathology
|
April 2, 2025
HER2 mRNA Score From Quantitative ERBB2 mRNA Expression of Oncotype Dx : Can It Replace the HER2 Immunohistochemistry?
Hyunwoo Lee, Jai Min Ryu, Se Kyung Lee, et al.
Scientific Reports
|
August 31, 2021
Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients
Soo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, et al.
Page
of 16